Kenya Medical Research Institute (Kemri) will launch the world's first Kala-azar vaccine trial in Baringo County, a significant step in combating a neglected tropical disease.

• The trial will take place at the Chemolingot Kala-azar Centre in Tiaty Central, an area with high infection rates.
• Key figures involved include Kemri CEO Elijah Songok and Baringo Governor Benjamin Cheboi.
• Beyond Kala-azar, Kemri and the Baringo County Government are expanding collaboration to address other health challenges like hepatitis B and snakebites, with efforts to develop a locally tailored snake anti-venom underway.